News brief
On 2026-09-17, according to Xiniu Data, Lingchuangyigu completed Series C financing for an undisclosed amount. Investors were Beijing Jingji Technology Kaifaqu Science and Technology Innovation Guquan Investment Fund Phase Two (Limited Partnership). The company is a developer of neuromodulation and brain-computer interface medical devices.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月17日，据烯牛数据报道，领创医谷完成C轮融资，金额未披露。投资方为北京经济技术开发区科技创新股权投资基金二期（有限合伙）。该公司为神经调控及脑机接口医疗器械研发商。